TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive Research vs. Delivery? Advisors Debate NCI Role In Review of Community Program. November 21, 2008
TCL Archive DCT Board Okays Concepts Of Four New Grant Projects, Four Competitive Contract Delays Chlordane Study March 9, 1984